Vaccination in Spain has reduced infections in nursing homes

Over the month, the increase in incidence in institutions decreased from 4.4 thousand new cases per week to 215 cases.

In five communities in Spain, they analyzed data from nursing homes and found that after vaccination, the increase in coronavirus decreased sharply. El Pais reports this with reference to the Spanish Ministry of Health on Wednesday, March 3.

In particular, during the period from February 15 to February 21, 215 cases of the disease were registered in these institutions. Moreover, for the period from 18 to 24 January, 4439 people fell ill. In addition, in some institutions in the week of February 15, not a single case of the disease was recorded at all.

The changes are associated with the first effect of vaccination, but partly with the fact that the trend coincided with a decrease in the number of infections in the country as a whole: in the third week of February, 83% fewer cases were registered than in the third week of January.

Note that Spanish nursing homes have suffered greatly from the epidemic due to the fact that they live in people aged mainly over 80 years old, with a number of chronic diseases. In these institutions, 29,408 Spaniards have died due to the coronavirus.

Recall that the European Union is considering an emergency approval of COVID vaccines. The changes are due to criticism of the EU leadership for the slow vaccine approval process, which inhibits the immunization of the population.

It was also reported that the first South American country received vaccines through the COVAX mechanism. Colombia became the first nation in the Americas to receive the COVID vaccine for COVAX.

British scientists find out for whom COVID vaccines are more effective

Scientists in Britain have said coronavirus vaccines are more effective for younger people than older people.

Writes about this edition of the Mirror.

The Department of Health England believes that vaccines can provide better protection for young age groups. Compared to older people, young people have a lower risk of contracting coronavirus or dying from complications.

According to British experts, vaccination will reduce the incidence rate across the country, and after two doses, transmission can be almost completely prevented.

Also, the results of the study show that after vaccination with AstraZeneca, hospitalizations among people over 80 years old have decreased significantly.

Mary Ramsay, Head of Immunization at the Department of Health, England, said: “We were able to show that even if people do get COVID-19 after being vaccinated, their risk of hospitalization and death will be markedly reduced.”

Earlier, we wrote that AstraZeneca plans to develop a new generation of vaccines by the fall that will combat new strains of coronavirus.

We also wrote that the inhabitants of Germany refuse to be vaccinated with the drug of the AstraZeneca company. Doctors say they have used only 15% of the vaccine doses available.

In Poland, the British strain of coronavirus was called the cause of the development of the third wave

The British strain is the leading cause of the third wave of the coronavirus epidemic in Poland, the country’s health minister, Adam Niedzielski, said on Monday.

It is reported by Eur News with reference to RMF 24.

At a press conference, the minister was asked about the impact of the British strain of coronavirus on the daily number of cases. Nedzelsky acknowledged that this option is the main reason for the development of the third wave of the epidemic, which is confirmed by studies of the virus genome in regions of the country where there are a large number of cases.

He recalled that last week such a study was carried out in the Warminsko-Mazurskie Voivodeship. It showed that the British variant was responsible for 70% of the cases.

Similar studies have recently been carried out in the Pomeranian Voivodeship.

“There we have a share of the British mutation of 77%,” the minister stressed.

In Poland, 43,793 deaths from the virus have been reported today. Since February 9, the average seven-day rate of new infections has been on the rise.

We add that Polish President Andrzej Duda held talks with his Chinese counterpart Xi Jinping to buy a Chinese vaccine, as the country is looking for ways to speed up the vaccination of residents.

In Hungary, the president was vaccinated with the Chinese vaccine

Hungary uses vaccines from five manufacturers. More than half a million people have already received the first vaccination.

Hungarian President Janos Ader on Saturday, February 27, was vaccinated against the coronavirus by the Chinese company Sinopharm, Hungary Today reports.

The head of state urged to register for vaccination as early as possible, and also to appear to receive an injection as soon as the therapist notifies about it.

“Let’s trust our doctors, our healthcare system,” Ader said, adding that he hopes the epidemic will soon be over.

Sinopharm vaccine shipments to Hungary began on 16 February. They began to vaccinate her on February 24.

In total, vaccines from five manufacturers are used in Hungary. The first vaccination has already been given to more than 520 thousand people, and the second — 240 thousand.

Israel remains the leader in vaccination. There, about half of the population has already received the first dose of the vaccine, and 35% of citizens have received two doses.

The European Union has agreed on the need to introduce vaccination certificates

The leaders of the EU countries agreed on the need to introduce vaccination certificates. This was stated by German Chancellor Angela Merkel.

According to Merkel, we are talking about electronic certificates that will be ready within three months. “We were all United in the fact that we need it,” she said. The documents themselves will be developed by European countries, and the technical issues and compatibility of certificates in all EU states will be worked out by the European Commission.

The Chancellor noted that the certificates can become the basis for travel within the European Union, as well as for entry into its territory from third countries.